Literature DB >> 33793315

Making the Best of Limited Resources: Improving Outcomes in Head and Neck Cancer.

Johannes J Fagan1, Vanita Noronha2, Evan Michael Graboyes3.   

Abstract

The overwhelming majority of head and neck cancers and related deaths occur in low- and middle-income countries, which have challenges related to burden of disease versus access to care. Yet the additional health care burden of the COVID-19 pandemic has also impacted access to care for patients with head and neck cancer in the United States. This article focuses on challenges and innovation in prioritizing head and neck cancer care in Sub-Saharan Africa, the Indian experience of value-added head and neck cancer care in busy and densely populated regions, and strategies to optimize the management of head and neck cancer in the United States during the COVID-19 pandemic.

Entities:  

Mesh:

Year:  2021        PMID: 33793315      PMCID: PMC8059263          DOI: 10.1200/EDBK_320923

Source DB:  PubMed          Journal:  Am Soc Clin Oncol Educ Book        ISSN: 1548-8748


  73 in total

1.  Concomitant chemoradiation versus radical radiotherapy in advanced squamous cell carcinoma of oropharynx and nasopharynx using weekly cisplatin: a phase II randomized trial.

Authors:  A Sharma; B K Mohanti; A Thakar; S Bahadur; S Bhasker
Journal:  Ann Oncol       Date:  2010-04-28       Impact factor: 32.976

2.  Trends and variations in the use of adjuvant therapy for patients with head and neck cancer.

Authors:  Michelle M Chen; Sanziana A Roman; Wendell G Yarbrough; Barbara A Burtness; Julie A Sosa; Benjamin L Judson
Journal:  Cancer       Date:  2014-07-15       Impact factor: 6.860

3.  Improving patient outcomes through multidisciplinary treatment planning conference.

Authors:  Carol M Lewis; Zhannat Nurgalieva; Erich M Sturgis; Stephen Y Lai; Randal S Weber
Journal:  Head Neck       Date:  2015-12-22       Impact factor: 3.147

4.  A prospective randomized phase II study comparing metronomic chemotherapy with chemotherapy (single agent cisplatin), in patients with metastatic, relapsed or inoperable squamous cell carcinoma of head and neck.

Authors:  Vijay Maruti Patil; Vanita Noronha; Amit Joshi; Vamshi Krishna Muddu; Sachin Dhumal; Bharatsingh Bhosale; Supreeta Arya; Shashikant Juvekar; Shripad Banavali; Anil D'Cruz; Atanu Bhattacharjee; Kumar Prabhash
Journal:  Oral Oncol       Date:  2015-01-08       Impact factor: 5.337

5.  National evaluation of multidisciplinary quality metrics for head and neck cancer.

Authors:  John D Cramer; Sedona E Speedy; Robert L Ferris; Alfred W Rademaker; Urjeet A Patel; Sandeep Samant
Journal:  Cancer       Date:  2017-07-20       Impact factor: 6.860

6.  Quality indicators of laryngeal cancer care in the elderly.

Authors:  Christine G Gourin; Kevin D Frick; Amanda L Blackford; Robert J Herbert; Harry Quon; Arlene A Forastiere; David W Eisele; Sydney M Dy
Journal:  Laryngoscope       Date:  2014-02-22       Impact factor: 3.325

7.  A phase 2 randomized study to compare short course palliative radiotherapy with short course concurrent palliative chemotherapy plus radiotherapy in advanced and unresectable head and neck cancer.

Authors:  Arvind Kumar; Atul Sharma; Bidhu Kalyan Mohanti; Alok Thakar; Nootan Kumar Shukla; Sanjay P Thulkar; Kapil Sikka; Suman Bhasker; Chirom Amit Singh; Sreenivas Vishnubhatla
Journal:  Radiother Oncol       Date:  2015-08-21       Impact factor: 6.280

8.  Quantitative survival impact of composite treatment delays in head and neck cancer.

Authors:  Allen S Ho; Sungjin Kim; Mourad Tighiouart; Alain Mita; Kevin S Scher; Joel B Epstein; Anna Laury; Ravi Prasad; Nabilah Ali; Chrysanta Patio; Jon Mallen-St Clair; Zachary S Zumsteg
Journal:  Cancer       Date:  2018-05-09       Impact factor: 6.860

9.  Head and neck surgery recommendations during the COVID-19 pandemic.

Authors:  Thomas J Galloway; Luiz Paulo Kowalski; Leandro L Matos; Gilberto Castro Junior; John A Ridge
Journal:  Lancet Oncol       Date:  2020-09       Impact factor: 41.316

10.  Nimotuzumab-cisplatin-radiation versus cisplatin-radiation in HPV negative oropharyngeal cancer.

Authors:  Vanita Noronha; Vijay Maruti Patil; Amit Joshi; Manoj Mahimkar; Usha Patel; Manish Kumar Pandey; Arun Chandrasekharan; Hollis Dsouza; Atanu Bhattacharjee; Abhishek Mahajan; Nilesh Sabale; Jai Prakash Agarwal; Sarbani Ghosh-Laskar; Ashwini Budrukkar; Anil K D'Cruz; Pankaj Chaturvedi; Prathamesh S Pai; Devendra Chaukar; Sudhir Nair; Shivakumar Thiagarajan; Shripad Banavali; Kumar Prabhash
Journal:  Oncotarget       Date:  2020-01-28
View more
  1 in total

1.  Image-Guided Radiation Therapy for Squamous Cell Cancer of the Head and Neck in a Specialized Peruvian Public Hospital.

Authors:  Lissett Jeanette Fernández-Rodríguez; María Alejandra Arens-Benites; Xavier Maldonado-Pijoan
Journal:  Cureus       Date:  2022-02-24
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.